SPONSOR
Hinova Pharmaceuticals Inc.
Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 2
Hinova Pharmaceuticals Inc. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including MCRPC, NAFLD (Non-alcoholic Fatty Liver Disease).
The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Hinova Pharmaceuticals Inc.
How many clinical trials has Hinova Pharmaceuticals Inc. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Hinova Pharmaceuticals Inc., of which 2 are actively recruiting participants. These trials cover conditions including MCRPC, NAFLD (Non-alcoholic Fatty Liver Disease). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Hinova Pharmaceuticals Inc. research focus on?
Hinova Pharmaceuticals Inc. clinical trials span MCRPC, NAFLD (Non-alcoholic Fatty Liver Disease). The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Hinova Pharmaceuticals Inc. clinical trial?
To participate in a Hinova Pharmaceuticals Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Hinova Pharmaceuticals Inc. trials with current recruitment status updated daily.
Clinical Trials by Hinova Pharmaceuticals Inc.
NCT03851640 Phase 3
Recruiting
A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).
MCRPC
NCT07308548 Phase 2
Recruiting
A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH )
NAFLD (Non-alcoholic Fatty Liver Disease)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology